Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Active Biotech | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 100.22M | -2.3x | -0.05 | SEK 0.29 | 76.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Upgrade Invest Nordic AB | Spotlight | SEK 6.57M | SEK 4.50 | 39.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||||
Gabather | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 15.18M | -1x | 0.12 | SEK 0.64 | 35.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Simris Alg | Stockholm | Consumer Non-Cyclicals | Food & Tobacco | SEK 58.60M | -1x | -0.03 | SEK 0.12 | 32.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Medimi | Spotlight | Healthcare | Healthcare Equipment & Supplies | SEK 3.67M | -0.4x | -0.01 | SEK 0.004 | 29.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Northbaze Group | Stockholm | Technology | Computers, Phones & Household Electronics | SEK 35.17M | -2x | -0.04 | SEK 0.22 | 25.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Svenska Aerogel | Stockholm | Basic Materials | Chemicals | SEK 105.68M | -2x | -0.05 | SEK 0.12 | 22.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Hunter Capital AB | Spotlight | Consumer Cyclicals | Diversified Retail | SEK 21.24M | 1.8x | 0.02 | SEK 7.30 | 21.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
FX International | Spotlight | Financial | Investment Banking & Investment Services | SEK 23.38M | -0.5x | 0 | SEK 0.12 | 20.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Chosa Oncology AB | Spotlight | Healthcare | Biotechnology & Medical Research | SEK 37.60M | -7.4x | SEK 0.84 | 20% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |